LATEST ARTICLES

Sotrovimab Approval in the UK: A Monoclonal Antibody Effective Against Omicron,...

0
Sotrovimab, a Monoclonal antibody already approved for mild to moderate COVID-19 in several countries gets approval by MHRA in the UK. This antibody was intelligently designed...

Future of Adenovirus based COVID-19 Vaccines (such as Oxford AstraZeneca) in...

0
Three adenoviruses used as vectors to produce COVID-19 vaccines, bind to platelet factor 4 (PF4), a protein implicated in the pathogenesis of clotting disorders.  Adenovirus...

How Omicron Variant of COVID-19 may have Arisen?

0
One of unusual and most intriguing feature of heavily mutated Omicron variant is that it acquired all the mutations in a single burst in a...

Omicron variant: UK and USA Authorities recommend Booster doses of COVID...

0
In order to raise levels of protection across the population against the Omicron variant, the Joint Committee on Vaccination and Immunisation (JCVI)1 of UK has...

Soberana 02 and Abdala: World’s first Protein conjugate Vaccines against COVID-19

0
The technology used by Cuba to develop protein-based vaccines against COVID-19 can lead to development of vaccines against new mutated strains in a relatively...

Spinal Cord Injury (SCI): Exploiting Bio-active Scaffolds to Restore Function

0
Self-assembled nanostructures formed using supramolecular polymers containing peptide amphiphiles (PAs) containing bio active sequences have shown great results in mouse model of SCI and holds immense promise, in...